NCT05349058View on ClinicalTrials.gov

Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors

UnknownOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

January 17, 2021

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions

MyocarditisImmune Checkpoint InhibitorsCardiotoxicityMyocardial Injury

Interventions

DRUG

Immune Checkpoint Inhibitors

Patients receive Immune Checkpoint Inhibitor as per oncology protocol

Trial Locations (1)

5042

RECRUITING

Flinders Medical Centre, Adelaide

Sponsors

Collaborators (1)

Flinders Medical Centre

All Listed Sponsors

collaborator

Flinders Medical Centre

OTHER_GOV

collaborator

Lyell McEwin Hospital

OTHER_GOV

lead

Flinders University

OTHER

NCT05349058 - Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors | Biotech Hunter | Biotech Hunter